A nomogram was constructed to predict the 1-, 3-, and 5-year survival of patients with CRC using factors such as T stage, N stage, M stage, age, CEA level, CDKN2A expression, GPX3 expression, and SLC7A11 expression (Figure 6A). This evidence concerns the gene GPX3 and colorectal carcinoma.